SOX11 and neuroblastoma: Higher expression levels of SOX11 both at mRNA and protein level were observed in MNA and MNoA NB tumors as compared to tumors with mesenchymal super-enhancer signature (Fig. 1g) as well as adrenergic compared to mesenchymal NB cell lines and tumors (Supplementary Fig. 1j–l).